GH - Guardant Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
70.51
-2.20 (-3.03%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close72.71
Open72.60
Bid69.01 x 800
Ask71.00 x 800
Day's Range68.10 - 72.65
52 Week Range27.04 - 106.58
Volume1,397,955
Avg. Volume1,095,617
Market Cap6.059B
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.80
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est81.75
Trade prices are not sourced from all markets
  • Top Gene-Sequencing Stocks for 2019
    Motley Fool2 days ago

    Top Gene-Sequencing Stocks for 2019

    These next-generation companies are working on game-changing ways to obtain and profit from genetic insight.

  • GlobeNewswire6 days ago

    NILE Study Results Demonstrating Guardant360’s High Concordance to Tissue Testing in Advanced NSCLC Published in Clinical Cancer Research

    Guardant Health, Inc. (GH), announced that the positive results from the NILE study, a head-to-head comparison of the Guardant360® assay to standard-of-care tissue testing for the identification of guideline-recommended biomarkers in first-line advanced non-small cell lung cancer (NSCLC) patients, have been published in Clinical Cancer Research1. The landmark study adds new data regarding Guardant360’s high concordance to tissue testing to the abstract that was highlighted before the AACR Annual Meeting and presented by the study’s senior author Vassiliki Papadimitrakopoulou, MD, Chief Section of Thoracic Medical Oncology, MD Anderson Cancer Center. The study adds to a growing body of literature2,3 demonstrating that using Guardant360 first for genomic biomarker detection in advanced NSCLC can increase the number of patients tested for guideline-recommended biomarkers.

  • Associated Press11 days ago

    JetBlue and Delta rise while WD-40 slips

    Stocks that moved substantially or traded heavily on Wednesday: JetBlue Airways Corp., up 58 cents to $16.92 The airline reported a 7.9% increase in air traffic in March, along with an increase in flight ...

  • Why First Solar, Guardant Health, and Tempur Sealy International Jumped Today
    Motley Fool11 days ago

    Why First Solar, Guardant Health, and Tempur Sealy International Jumped Today

    Positive comments and favorable industry conditions helped lift several stocks.

  • Benzinga11 days ago

    Bank Of America Upgrades Guardant Health On Huge Growth Potential

    While se Bruin says Guardant shares are admittedly expensive after its recent rally, the company’s massive growth potential has skewed the risk decidedly to the upside. De Bruin has been hesitant to get behind such a volatile stock with a steep valuation, but several factors have improved the stock’s outlook in recent weeks. First, Guardant’s LUNAR-1 data at the American Association of Cancer Research meeting was positive.

  • Why Guardant Health Stock Just Popped 10%
    Motley Fool11 days ago

    Why Guardant Health Stock Just Popped 10%

    What went up then came down again is going back up again.

  • Stocks Rise As Growth Leads: Delta Earnings Top; Hot IPO Offers Buying Opportunity
    Investor's Business Daily11 days ago

    Stocks Rise As Growth Leads: Delta Earnings Top; Hot IPO Offers Buying Opportunity

    Growth stocks led an early rally. Wednesday. Delta Air Lines rose on earnings. Levi Strauss and hot IPO stock Guardant Health jumped. Apple got a sell rating.

  • GlobeNewswire12 days ago

    Guardant Health Announces Commercial Payer Progress with more than 150 Million Lives Covered for Guardant360

    Guardant Health, Inc. (GH), announced that its market leading liquid biopsy, Guardant360®, will be a covered benefit for the members of the health plans associated with eviCore, a technology assessment company. The test will be considered medically necessary to assist in selecting therapy for patients with advanced lung cancer. When the eviCore policy becomes effective July 1, Guardant360 will have added coverage for over 38 million lives in 2019, including with Health Care Service Corporation in Illinois, Montana, New Mexico, Oklahoma, and Texas, Independence Blue Cross, Highmark Blue Cross Blue Shield, Blue Cross Blue Shield of Tennessee, and Government Employees Health Association/Federal Employees Program.

  • Here's Why Guardant Health Stock Gained 15.1% in March
    Motley Fool12 days ago

    Here's Why Guardant Health Stock Gained 15.1% in March

    The liquid biopsy pioneer has been riding a wave of favorable news lately.

  • GlobeNewswire24 days ago

    Palmetto GBA issues Draft Local Coverage Determination Expanding Guardant360 Medicare Coverage to Most Solid Tumor Types

    Guardant Health, Inc. (GH), announced that Palmetto GBA, a Medicare Administrative Contractor, has posted a draft local coverage determination (LCD) expanding Medicare coverage of the Guardant360® assay from advanced non-small cell lung cancer (NSCLC) to over a dozen advanced solid tumor cancer types with guideline-recommended genomic targets. The draft LCD would apply to advanced cancer patients who are covered by Medicare for next-generation sequencing of tumor tissue, but have insufficient or unavailable tissue samples. “This is an important step toward making sure all Medicare beneficiaries with advanced cancer have timely access to guideline-recommended treatment options,” said Guardant Health co-founder and CEO Helmy Eltoukhy, PhD.

  • GlobeNewswire25 days ago

    Guardant Health Announces Definitive Agreement to Acquire Bellwether Bio

    Guardant Health, Inc. (GH), announced that it has entered into a definitive agreement to acquire Bellwether Bio, Inc., a privately held company focused on improving oncology patient care through their pioneering research into the epigenomic content of cell free DNA.  The transaction is expected to close in April 2019. The Bellwether Bio team will join Guardant Health to further advance its early detection product pipeline.  The team includes Jay Shendure, MD, PhD, who will act as a scientific advisor to Guardant Health.

  • 3 Stocks That Are Up More Than 100% in 2019
    Motley Fool28 days ago

    3 Stocks That Are Up More Than 100% in 2019

    It can take years for a stock to double -- if it does at all. These three did it in less than three months.

  • Better Buy: Illumina vs. Guardant Health
    Motley Foollast month

    Better Buy: Illumina vs. Guardant Health

    How wide are the moats for these healthcare growth stocks?

  • Benzingalast month

    Jim Cramer Weighs In On Alibaba, Kimberly Clark And More

    On CNBC's "Mad Money Lightning Round" , Jim Cramer said that Guardant Health Inc (NASDAQ: GH ) is a winner. The acquisition of Red Hat is going to help IBM (NYSE: IBM ) greatly, said Cramer. ...

  • GuruFocus.comlast month

    Guardant Health Inc (GH) Files 10-K for the Fiscal Year Ended on December 31, 2018

    For the last quarter Guardant Health Inc reported a revenue of $32.9 million, compared with the revenue of $11.13 million during the same period a year ago. Warning! GuruFocus has detected 3 Warning Signs with GH. The Guardant Health Inc had an operating margin of -102.54%, compared with the operating margin of -153.71% a year before.

  • 3 More Stocks That Have More Than Doubled in 2019
    Motley Foollast month

    3 More Stocks That Have More Than Doubled in 2019

    Snap, Guardant Health, and Yeti are big winners so far in 2019.

  • Guardant Health (GH) Q4 2018 Earnings Conference Call Transcript
    Motley Foollast month

    Guardant Health (GH) Q4 2018 Earnings Conference Call Transcript

    GH earnings call for the period ending December 31, 2018.

  • This Recent Diagnostics IPO Is Having An Astronomical Run — Here's Why
    Investor's Business Dailylast month

    This Recent Diagnostics IPO Is Having An Astronomical Run — Here's Why

    Diagnostics company Guardant Health has had an astronomical stock run this month on positive data for its cancer-treatment blood tests, known as G360, and a strong fourth-quarter report.

  • Harry Boxer’s 4 stocks running on earnings
    MarketWatchlast month

    Harry Boxer’s 4 stocks running on earnings

    OUTSIDE THE BOX Here are four stocks to watch with strong price momentum fueled by earnings. Denali Therapeutics Inc. (DNLI) jumped $2.17 to $24.37 on 1.19 million shares Wednesday, nearly three times its average volume.

  • Associated Presslast month

    Vera Bradley and Guardant Health surge while Express falls

    Stocks that moved substantially or traded heavily on Wednesday: Rite Aid Corp., up 4 cents to 72 cents The drugstore chain purged its top management, including CEO John Stanley, and said it will cut 400 ...

  • Why Oaktree Capital Group, Guardant Health, and Clean Energy Fuels Jumped Today
    Motley Foollast month

    Why Oaktree Capital Group, Guardant Health, and Clean Energy Fuels Jumped Today

    Merger and acquisition news and solid earnings helped give the market a lift.

  • TheStreet.comlast month

    Guardant Health Posts Healthy Post-Earnings Gains

    posted healthy gains on Wednesday after the company reported a fiscal fourth-quarter loss that was narrower than analysts' expectations. Guardant Health shares surged almost 14%, gaining $10.19 to $84.19 on the New York Stock Exchange, after the company said it lost $25.1 million, or 30 cents a share, in its most recent fiscal quarter, vs. a year-earlier loss of $15.1 million, or $1.27 a share. For 2019, Guardant Health said it expects full-year revenue in the range of $130 million to $135 million, though it also expects to record a loss in the range of $126 million to $129 million.

  • Guardant Health Is Growing Like Gangbusters
    Motley Foollast month

    Guardant Health Is Growing Like Gangbusters

    The liquid biopsy leader continues to expand at a rapid pace, and management expects more of the same in 2019.

  • Why Guardant Health Is Roaring Higher Today
    Motley Foollast month

    Why Guardant Health Is Roaring Higher Today

    Shares soar after the company reports strong fourth-quarter results and calls for more of the same in 2019.

  • Dow Jones Futures: This Big-Cap Index Is Leading Now; Red-Hot IPO Tops Views
    Investor's Business Dailylast month

    Dow Jones Futures: This Big-Cap Index Is Leading Now; Red-Hot IPO Tops Views

    Apple, Microsoft and Google pushed the Nasdaq 100 index to a stock market rally high. Hot IPO Guardant Health rose on strong Q4 results.